Former Airbus CEO Dr. Thomas Enders to serve as Lilium’s Chairman of the Board following business combination with Qell
Lilium has announced advisory board member Dr. Thomas Enders will become Chairman of the Board of Directors of Lilium N.V., upon completion of Lilium’s business combination with Qell Acquisition Corp.
The German startup plans to go public as part of a joint SPAC merger with Qell, which was announced in March and will value the new company at approximately $3.3 billion. The transaction is expected to be completed in the second quarter of 2021.
Dr. Enders, who served as the CEO of Airbus during a career in aerospace spanning 30 years, joined Lilium’s Advisory Board in January 2021, and an announcement was part was made as part of Lilium’s inaugural Analyst Day which was held virtually yesterday (Tuesday).
Lilium’s executive team, including team members who worked on developing some of the most successful aircraft in aviation history, shared more information on certification plans, manufacturing approach, business model and commercial relationships with established industry suppliers and infrastructure developers.
There was also a first look at the cabin of the seven-seater Lilium Jet, which has space for six passengers and one pilot, spacious window seats, clear views, a central aisle and a separate hold for luggage.
Dr Enders said: “I would be honored to lead the first Board of Lilium once the business combination is completed and am grateful for the confidence my colleagues put in me. Now, I’m focused on expanding this world-class board of directors to support CEO Daniel Wiegand and his great management team, and set the course for success.”
Daniel Wiegand, Co-Founder and CEO of Lilium, said: “Tom Enders is an aviation industry giant, and we are all delighted to see him reaffirm his commitment to Lilium by accepting the future role of Chairman of the Board when Lilium becomes a Nasdaq-listed company.
“We will continue to leverage Tom’s incredible network across aerospace, both in the delivery of aircraft and in commercial development, and together with Barry Engle and the directors who will serve on the Board of Directors of Lilium N.V., Tom will provide important counsel and stewardship as we prepare for a planned commercial launch in 2024.”
In a video message, Dr. Enders discussed the importance of Lilium’s commercial relationships to the company’s future success, which includes Honeywell Aerospace, Palantir, Lufthansa Aviation Training and Ferrovial – and their anticipated contribution to development and commercialization of the Lilium Jet.
Honeywell Aerospace will work with Lilium to reduce certification schedule risk and cost by providing avionics and fly-by-wire flight controls.
Palantir, which along with Honeywell have committed to invest in Lilium through the previously announced PIPE offering in connection with Lilium’s business combination with Qell, will provide enterprise-grade intelligence and a data-first approach to support the manufacturing and delivery of the 7‑Seater Lilium Jet;
Lufthansa Aviation Training is developing bespoke pilot sourcing and training programs to qualify pilots to fly the Lilium Jet
Ferrovial is working with Lilium to plan and develop a network of at least ten vertiports in major cities across Florida, Lilium’s planned launch market in the U.S.
Barry Engle, Founder and CEO of Qell and who is also part of Lilium’s Board of Directors, added: “Tom Enders needs no introduction, having led one of the world’s most successful aerospace companies as part of a successful career. He will bring enormous industry insights, experience, and foresight in corporate governance to Lilium, and we look forward to having Tom serve as Chairman of the Board as Lilium develops and seeks certification for the 7‑Seater Jet.”